Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …

OBJECTIVE: The number of umbilical cord blood transplants is increasing worldwide. At this
time, it is important to evaluate their results and to compare the outcome of umbilical cord …

Since the first human cord blood transplant, performed in 1988, cord blood banks have been
established worldwide for collection and cryopreservation of cord blood for allogeneic …

THE clinical manifestations of Fanconi's anemia, an autosomal recessive disorder, include
progressive pancytopenia, a predisposition to neoplasia, and nonhematopoietic …

Background Cord-blood banks have increased the use of cord-blood transplantation in
patients with hematologic disorders. We have established a registry containing information …

The β-haemoglobinopathies are the most prevalent inherited disorders worldwide. Gene
therapy of β-thalassaemia is particularly challenging given the requirement for massive …

Background Promising results of cord-blood transplants from unrelated donors have been
reported in adults. Methods We compared outcomes in 682 adults with acute leukemia who …

Background Umbilical-cord blood as an alternative to bone marrow for hematopoietic stem-
cell transplantation may lower the risk of graft-versus-host disease (GVHD). Methods We …

In order to compare the outcomes of unrelated umbilical cord blood transplants (UCBTs) or
bone marrow transplants, 541 children with acute leukemia (AL) transplanted with umbilical …

Data on 405 patients with chronic myelogenous leukemia who received bone marrow
transplants in chronic phase were analyzed for factors predictive of outcome. The 4-year …